Indian Army Medical Supplies Tender 2026: Pharmaceutical Kit & Topical Creams Procurement for Department of Military Affairs in India (GEM/2026/B/7336825)

Tender Overview

The Indian Army (Department of Military Affairs) issues a pharmaceutical procurement tender for a range of medications and topical preparations, including analgesics, antibiotics, cardiovascular drugs, thyroid replacement, antifungals, and wound care creams. The project presents a 17-item BoQ with an estimated value not disclosed and an EMD of ₹3,651. The award requires adherence to an optional order quantity variation of up to ±25%, with delivery timing linked to the original delivery schedule and extended periods. The tender emphasizes supply of multiple drug categories and OTC items, with no explicit storage or packaging standards stated in the data. The absence of explicit location details suggests national, centralized distribution to defence medical stores, with mandatory compliance to the buyer’s ATC terms. A critical differentiator is the option clause on quantity and the need to manage variable orders within contracted rates.

Technical Specifications & Requirements

• Product categories include: analgesics, antibiotics (Azithro 1 g, Fluconazole 150 mg), anti-viral/antifungal, anti-hypertensives (Enalapril 5 mg), anti-diabetics (Acarbose 25 mg, Voglibose 0.3 mg), thyroid hormone (Thyroxine 75 mcg), vitamins with minerals (Calcium with Vitamin D3), topical: Mupirocin 2% ointment, Silver Sulphadiazine 1% cream, Diclofenac spray, and other listed drugs.
• No explicit technical standards or packaging specifications are provided in the tender data; the EMD amount is ₹3,651 and the BOQ lists 17 items with no itemized quantities.
• The ATC/terms document references a generic option clause for quantity variation and delivery calculations; bidders should prepare to align with the clause: additional time = (Increased quantity ÷ Original quantity) × Original delivery period, minimum 30 days.
• Jurisdiction appears national; bidders must demonstrate capability to supply a wide pharmaceutical spectrum under defence procurement norms.

Terms, Conditions & Eligibility

• EMD: ₹3,651 (mode unspecified in data; expect DD/online transfer per terms)
• Delivery: Delivery schedule linked to original delivery order; option to extend with proportional time; minimum 30 days for any extension
• Quantity Variations: ±25% of bid/contract quantity allowed during order and currency of contract
• BOQ: 17 items; no explicit unit quantities provided in the data; bidders must rely on official tender documents for itemized requirements
• ATC/ATC Document: Buyer uploaded ATC document; bidders should review for compliance and special conditions
• Location: Not explicitly specified; procurement appears to be under central defence medical stores
• Payment Terms: Not specified in the data; typical government terms apply but must be verified in terms & conditions
• Warranty/Penalties: Not specified in the data; ATC may contain specifics; bidders should review for LDs or penalties
• Brand/OEM: Not specified; no explicit brand requirements listed